PharmiWeb.com - Global Pharma News & Resources
08-Jul-2019

Q Fever Market Worth Around 9,850.65 Million USD and Showcase Approximately Lucrative CAGR of Around 7.83% In International Market Forecast Till 2023

The Global Q Fever Market is expected to reach a market value of USD 9,850.65 million by 2023 from USD 6,249.68 million in 2017 and is expected to register a CAGR of 7.83% during the forecast period of 2018 to 2023.

Introduction

Q fever is a mild disease with flu-like symptoms. In Q fever, the infection is caused by the bacterium Coxiella burnetii. Many patients have no symptoms at all, while, in some cases, the infection could reoccur/resurface years later. Chronic Q fever may damage the heart, liver, brain, lungs, and could cause diabetes in some cases.
The major factors driving the growth of the market include rising prevalence of Q fever coupled with increasing Q fever hospitalization rates, rising worldwide cattle, sheep, and goat population, growth in risk factors of Q fever, and globally growing geriatric population.
The global Q fever market has been segmented on the basis of type, diagnosis, treatment, end user, and region.
The global Q fever market, by type, has been segmented into acute and chronic.
The global Q fever market, by diagnosis, has been segmented into serology tests and others.
The global Q fever market, by treatment, has been segmented into antibiotics and surgery.
The global Q fever market, by end user, has been segmented into patients, hospitals and clinics, and others.

We can provide sample pages for a better understanding of this report.
Request Sample of This Report @ http://www.amecoresearch.com/sample/14696

The global Q fever market is expected to reach a market value of USD 9,850.65 million by 2023 from USD 6,249.68 million in 2017 and is expected to register a CAGR of 7.83% during the forecast period of 2018 to 2023. In 2017, Asia-Pacific held the highest share of the market at 44.9%, followed by the Middle East and Africa with a share of 25.4%.

Key Players

Merck KGaA, Teva Pharmaceutical Industries Ltd, Pfizer Inc., Basilea Pharmaceutica Ltd, Sanofi S. A., Melinta Therapeutics, Inc., Bayer AG, Johnson amp; Johnson Services, Inc., Yashica Pharmaceuticals, and AtoxBio.
Study Objectives

bull; To provide a detailed analysis of the market structure along with the forecast of various segments and sub-segments of the Q fever market
bull; To provide insights into factors affecting the market growth
bull; To analyze the global Q fever market based on various tools such as supply chain analysis and Porter's five force analysis
bull; To provide historical and forecast revenue of market segments and sub-segments with respect to regions and their respective key countries
bull; To provide country-level analysis of the market with respect to the current market size and future perspective
bull; To provide country-level analysis of the market for segments by type, diagnosis, treatment, end user, and region
bull; To provide strategic profiling of key players in the market, comprehensively analyzing their core competencies and drawing a competitive landscape for the market
bull; To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the Q fever market

Target Audience

bull; Hospitals
bull; Q fever Companies
bull; Associations and Organizations
Key Findings

bull; The global Q fever market is expected to reach USD 9,850.65 million by 2023 at a CAGR of 7.83% from 2018 to 2023
bull; On the basis of type, the chronic segment accounted for the largest market share in 2017 and is expected to grow at a CAGR of 7.33% during the forecast period
bull; On the basis of diagnosis, the serology tests segment accounted for the largest market share in 2017 and is expected to grow at a CAGR of 8.32% during the forecast period
bull; On the basis of treatment, the antibiotics segment accounted for the largest market share in 2017 and is expected to grow at a CAGR of 7.32% during the forecast period
bull; On the basis of end user, the patients segment accounted for the largest market share in 2017 and is expected to grow at a CAGR of 8.21% during the forecast period
Regional Analysis

bull; Americas
o North America
 US
 Canada
o Latin America
bull; Europe
o Germany
o France
o UK
o Italy
o Spain
o Rest of Europe
bull; Asia-Pacific
o Japan
o China
o India
o Australia
o Republic of Korea
o Rest of Asia-Pacific
bull; Middle East amp; Africa
o UAE
o Saudi Arabia
o Oman
o Kuwait
o Qatar
o Africa
o Rest of the Middle East amp; Africa

View Detail Report With Complete Table Of Content@ http://www.amecoresearch.com/market/global-q-fever-market-mrfr-14696

Table Of Contents:

Global Q Fever Market Research Report Forecast to 2023

1 Report prologue
2 Market Introduction
2.1 Definition
2.2 Scope of the Study
2.3 Assumptions amp; Limitations
2.3.1 Assumptions
2.3.2 Limitations
2.4 Market Structure
3 Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
3.5 Forecast Model
4 Market Dynamics
4.1 Introduction
4.2 Drivers
4.2.1 Worldwide Rising Prevalence of Q fever Coupled with Increasing Q Fever Hospitalization Rates
4.2.2 Rising Worldwide Cattle, Sheep, and Goat Population
4.2.3 Growth in the Risk Factors of Q Fever
4.2.4 Globally Growing Geriatric Population
4.3 Restraints
4.3.1 High Cost of Diagnostic Tests
4.3.2 Lack of Awareness About Q Fever
4.4 Opportunity
4.4.1 Presence of Untapped Opportunities in the Asia-Pacific and African Regions
4.5 Market Trends
4.6 Macroeconomic Indicators
5 Market Factor Analysis
5.1 Porterrsquo;s Five Forces Model
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Rivalry
5.2 Supply Chain Analysis
5.2.1 Ramp;D and Development
5.2.2 Manufacturing
5.2.3 Distribution amp; Sales
5.2.4 Post-Sales Monitoring
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
6 Global Q Fever Market, By Type
6.1 Overview
6.2 Acute
6.3 Chronic
7 Global Q Fever Market, By Diagnosis
7.1 Overview
7.2 Serology Tests
7.3 Others
8 Global Q Fever Market, By Treatment
8.1 Overview
8.2 Antibiotics
8.3 Surgery
9 Global Q Fever Market, By End-User
9.1 Overview
9.2 Patients
9.3 Hospitals
9.4 Others
10 Global Q Fever Market, By Region
10.1 Overview
10.2 Americas
10.2.1 North America
10.2.1.1 US
10.2.1.2 Canada
10.2.2 Latin America
10.3 Europe
10.3.1 Germany
10.3.2 France
10.3.3 UK
10.3.4 Italy
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia-Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 South Korea
10.4.6 Rest of Asia-Pacific
10.5 Middle East amp; Africa
10.5.1 UAE
10.5.2 Saudi Arabia
10.5.3 Oman
10.5.4 Kuwait
10.5.5 Qatar
10.5.6 Africa
10.5.7 Rest of Middle East amp; Africa
11 Company Profile
11.1 Merck KGaA
11.1.1 Company Overview
11.1.2 Financial Overview
11.1.3 Products/Services Offered
11.1.4 SWOT Analysis
11.1.5 Key Developments
11.1.6 Key Strategies
11.2 Teva Pharmaceutical Industries Ltd
11.2.1 Company Overview
11.2.2 Financial Overview
11.2.3 Products/Services Offered
11.2.4 Key Developments
11.2.5 SWOT Analysis
11.2.6 Key Strategies
11.3 Pfizer Inc.
11.3.1 Company Overview
11.3.2 Financial Overview
11.3.3 Products/Services Offered
11.3.4 SWOT Analysis
11.3.5 Key Developments
11.3.6 Key Strategies
11.4 Basilea Pharmaceutica Ltd
11.4.1 Company Overview
11.4.2 Financial Overview
11.4.3 Products/Services Offered
11.4.4 Key Developments
11.4.5 SWOT Analysis
11.4.6 Key Strategies
11.5 Sanofi S. A.
11.5.1 Company Overview
11.5.2 Financial Overview
11.5.3 Products/Services Offered
11.5.4 SWOT Analysis
11.5.5 Key Developments
11.5.6 Key strategies
11.6 Melinta Therapeutics, Inc.
11.6.1 Company Overview
11.6.2 Financial Overview
11.6.3 Products/Services Offered
11.6.4 Key Developments
11.6.5 SWOT Analysis
11.6.6 Key Strategies
11.7 Bayer AG
11.7.1 Company Overview
11.7.2 Financial Overview
11.7.3 Products/Services Offered
11.7.4 SWOT Analysis
11.7.5 Key Developments
11.7.6 Key Strategies
11.8 Johnson amp; Johnson Services, Inc.
11.8.1 Company Overview
11.8.2 Financial Overview
11.8.3 Products/Services Offered
11.8.4 SWOT Analysis
11.8.5 Key Developments
11.8.6 Key Strategies
11.9 Yashica Pharmaceuticals
11.9.1 Company Overview
11.9.2 Financial Overview
11.9.3 Products/Services Offered
11.9.4 Key Developments
11.9.5 SWOT Analysis
11.9.6 Key Strategies
11.1 AtoxBio
11.10.1 Company Overview
11.10.2 Financial Overview
11.10.3 Products/Services Offered
11.10.4 Key Developments
11.10.5 SWOT Analysis
11.10.6 Key Strategies
12 Appendix
12.1 Discussion Blue Print

Quick Buy This Premium Report From Here: http://www.amecoresearch.com/buy/14696

About Us:

Ameco Research is the one spot destination for all your research needs. Ameco Research holds the repository of quality research reports from numerous publishers across the globe. Our inventory of research reports caters to various industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. With the complete information about the publishers and the industries they cater to for developing market research reports, we help our clients in making purchase decision by understanding their requirements and suggesting best possible collection matching their needs.

Contact:

Email: sales@amecoresearch.com | +1 407 915 4157

Editor Details

Last Updated: 08-Jul-2019